Answers are grounded in this paper and cite their sources.
There is an urgent need to find the most cost-effective treatment to help manage the ‘epidemic of obesity’. This study examined the long-term efficacy of lifestyle, pharmaceutical and surgical interventions of reducing weight in obese patients by carrying out a meta-analysis of published studies. English language randomized controlled trials were identified from Pubmed and the Cochrane Library in March 2013 that examined interventions for a minimum of 1 year in adults aged 18–70 years. Trials were selected on the basis of a Jadad score of >2 for pharmaceutical interventions and >1 for surgical interventions. Exercise and diet-combined therapy was more effective in producing weight loss than diet alone (mean of 5.18 ± 3.37 kg vs. 3.54 ± 3.67 kg), with a mean difference of 1.26 kg with 95% confidence interval (CI): 0.35–2.17 kg). Bariatric surgery resulted in a mean of 16.82% more body weight lost compared with a control group (95% CI: 14.60–19.03%). With respect to drug therapies, patients treated with lorcaserin lost a mean of 3.23 kg (95% CI: 2.70 to 3.75 kg) more than placebo (or 3.00% at 95% CI: 3.41–2.59). In contrast, patients treated with orlistat only lost a mean of 2.85 kg more than placebo (95% CI: 2.49–3.20 kg), equivalent to 2.88% (95% CI: 2.43–3.33%). These results indicate that bariatric surgery is the most effective intervention at causing clinically significant long-term weight loss, for patients with a body mass index of >35 kg/m2. However, it is also associated with considerable risks. Further research is also needed to identify whether lorcaserin or orlistat have a greater effect in particular patient sub-groups and examine the long-term efficacy of other drugs currently used off label for weight loss.
No takes yet. Share an insight, caveat, or question.
Justin S. Lawley (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: